Board of Directors
Elected annually by our shareholders, the Board of Directors is the company's ultimate decision-making body. The directors select and monitor the performance of our senior executives on Bristol-Myers Squibb's Leadership Team, who are responsible for the day-to-day operation of the company. Directors also act as advisors and counselors to our senior management.
Giovanni Caforio, M.D.
Chairman of the Board and Chief Executive Officer, Bristol-Myers Squibb
Vicki L. Sato, Ph.D.
Lead Independent Director, Bristol-Myers Squibb and Chairman of the Board, Denali Therapeutics, Inc.
Peter J. Arduini
President and Chief Executive Officer of Integra LifeSciences Holdings Corporation
Robert J. Bertolini
Former President and Chief Financial Officer of Bausch & Lomb Incorporated
Michael W. Bonney
Executive Chair, Kaleido Biosciences, Inc.
Matthew W. Emmens
Retired Chief Executive Officer and Chairman of the Board of Shire PLC
Retired Vice Chairman of Ernst & Young LLP
Julia A. Haller, M.D.
Ophthalmologist-in-Chief, Wills Eye Hospital
Alan J. Lacy
Former Non-Executive Chairman, Dave & Buster's Entertainment, Inc.
Dinesh C. Paliwal
President and Chief Executive Officer, Harman International
Theodore R. Samuels
Retired President of Capital Guardian Trust Company
Gerald L. Storch
Chief Executive Officer, Storch Advisors
Karen H. Vousden, Ph.D.
Senior Group Leader, The Francis Crick Institute and Chief Scientist, Cancer Research UK
Phyllis R. Yale
Advisory Partner, Bain & Company